Two Leading Cancer Researchers Appointed as Officers of the Order of Canada
The CCRA congratulates Drs. Anne-Marie Mes-Masson and John Bell, two distinguished cancer researchers and past CCRA awardees, for their appointments as Officers of the Order of Canada in late December 2025.
Anne-Marie Mes-Masson, PhD, FCAHS, FRSC, Associate Scientific Director of basic and translational research at the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), is recognized for her work in developing biobanks and significant scientific discoveries in ovarian and prostate cancer. A global leader in molecular oncology, her translational research has improved both precision health and therapeutic approaches.
John Bell, PhD, FRSC, FCAHS, a Senior Scientist at The Ottawa Hospital Research Institute, Professor of Medicine at the University of Ottawa, Scientific Director of BioCanRx, and member of the Centre for Cancer Therapeutics at The Ottawa Hospital Cancer Centre, is recognized as a renowned leader in the development of oncolytic virotherapy. His entrepreneurial efforts to build Canada’s capacity to discover, develop, test, and manufacture cell-based therapies have enabled Canadian leadership in immunotherapies.
New Member to the CCRA Advisory Board
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a P... Read More »
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a P... Read More »
Are You the Next Scientific Director of CIHR’s Institute of Cancer Research?
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This positi... Read More »
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This positi... Read More »